Synopsis
Nature Biotechnology podcast is a series of conversations with founders, financers and developers from biotechs past, present and future.
Episodes
-
![First Rounder: Henri Termeer]()
First Rounder: Henri Termeer
07/03/2013 Duration: 41minHenri Termeer discusses his path to Genzyme, the approval of Ceredase and the drawn-out negotiations with eventual acquirer Sanofi. See acast.com/privacy for privacy and opt-out information.
